+971509379212

AIIMS Jodhpur Confirms Ashwagandha Cortisol Reduction in Larger RCT

Back to news
Research

A 360-patient RCT at AIIMS Jodhpur shows standardised Ashwagandha extract reduced serum cortisol by 22% over 90 days in chronic stress, replicating earlier smaller trial results.

Dr. Priya Ramesh·Clinical Research Editor· 3 Jun 2026 1 min 1,450

An AIIMS Jodhpur team has published a 360-patient double-blind placebo-controlled trial of standardised Ashwagandha (KSM-66) for chronic stress, replicating and extending the 2012 Chandrasekhar findings.

Key results

  • Serum cortisol reduction: 22% (placebo: 4%)
  • DASS-21 stress score reduction: 35% (placebo: 11%)
  • PSQI sleep quality improvement: 28%
  • Adverse events: mild GI upset in 6%; no serious events
  • Dose was 600 mg standardised extract twice daily for 90 days.

    Why this matters

    The original Chandrasekhar 2012 trial showed 27.9% cortisol reduction in 64 patients. Multiple smaller replications have followed, but this is the first large adequately-powered trial. The convergent evidence is now substantial — Ashwagandha for stress-related cortisol elevation is one of the best-evidenced herbal interventions in Ayurveda.

    Interaction note

    The trial team explicitly excluded patients on thyroxine. Ashwagandha can stimulate thyroid output, and combining with prescribed thyroxine without supervision risks iatrogenic hyperthyroidism. AyurConnect's interaction checker flags this combination.

    Practical use

    600 mg KSM-66 or 5 g classical Ashwagandha Choornam with warm milk at bedtime, 60-90 days, then reassess. Check thyroid status before starting.

    Source: Journal of Ayurveda and Integrative Medicine · link

    Share: WhatsApp
    AIIMS Jodhpur Confirms Ashwagandha Cortisol Reduction in Larger RCT | AyurConnect News | AyurConnect